Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000930413-25-001275
Filing Date
2025-04-17
Accepted
2025-04-17 07:27:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 c112527_defa14a.htm DEFA14A 49665
  Complete submission text file 0000930413-25-001275.txt   50696
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 25844307
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)